Pay in 4 interest-free payments of $5.97 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Support your body's ability to protect itself
Research in Pharmaceuticals (MDPI, 2025) reviews BPC-157's mechanisms across tissue injury and repair models, documenting its effects via VEGFR2-Akt-eNOS angiogenic pathways, nitric oxide signaling, and growth hormone receptor expression upregulation in tendon fibroblasts
According to Drucker the findings, published in December 2023, provided the first demonstration of 'a GLP-1-brain-immune axis that controls inflammation across the body independent of weight loss, even in peripheral organs devoid of GLP1 receptors.' Drucker's team has not yet identified which particular brain cells interact with GLP-1 (AAAS)
These small changes are the earliest visible signs of the transformation that will accelerate dramatically over the coming months
US$ 23.40
US$ 26.12
US$ 24.49
